| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)
CRBP Technical Analysis
5
| As on 9th Jun 2023 CRBP STOCK Price closed @ 8.73 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.31 & Strong Buy for SHORT-TERM with Stoploss of 0.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRBPSTOCK Price
| Open | 9.32 | Change | Price | % |
| High | 9.55 | 1 Day | -0.59 | -6.33 |
| Low | 8.73 | 1 Week | -0.74 | -7.81 |
| Close | 8.73 | 1 Month | 1.02 | 13.23 |
| Volume | 37000 | 1 Year | 8.06 | 1202.99 |
| 52 Week High 12.00 | 52 Week Low 0.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRBP Daily Charts |
CRBP Intraday Charts |
Whats New @ Bazaartrend |
CRBP Free Analysis |
|
|
CRBP Important Levels Intraday
| RESISTANCE | 10.31 |
| RESISTANCE | 9.80 |
| RESISTANCE | 9.49 |
| RESISTANCE | 9.18 |
| SUPPORT | 8.28 |
| SUPPORT | 7.97 |
| SUPPORT | 7.66 |
| SUPPORT | 7.15 |
CRBP Forecast April 2024
| 4th UP Forecast | 9.19 |
| 3rd UP Forecast | 9.04 |
| 2nd UP Forecast | 8.95 |
| 1st UP Forecast | 8.86 |
| 1st DOWN Forecast | 8.6 |
| 2nd DOWN Forecast | 8.51 |
| 3rd DOWN Forecast | 8.42 |
| 4th DOWN Forecast | 8.27 |
CRBP Weekly Forecast
| 4th UP Forecast | 8.94 |
| 3rd UP Forecast | 8.87 |
| 2nd UP Forecast | 8.83 |
| 1st UP Forecast | 8.79 |
| 1st DOWN Forecast | 8.67 |
| 2nd DOWN Forecast | 8.63 |
| 3rd DOWN Forecast | 8.59 |
| 4th DOWN Forecast | 8.52 |
CRBP Forecast2024
| 4th UP Forecast | 33.92 |
| 3rd UP Forecast | 25.84 |
| 2nd UP Forecast | 20.85 |
| 1st UP Forecast | 15.85 |
| 1st DOWN Forecast | 1.61 |
| 2nd DOWN Forecast | -3.39 |
| 3rd DOWN Forecast | -8.38 |
| 4th DOWN Forecast | -16.46 |
Corbus Pharmaceuticals Holdings Inc ( NASDAQ USA Symbol : CRBP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRBP Business Profile
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. Its lead product candidate is lenabasum, a cannabinoid receptor type 2 (CB2) that is in Phase III clinical trial for the treatment of dermatomyositis; and in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing cannabinoid receptor type 1 inverse agonist program for treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; and CB2 agonist program for the treatment of cancer. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Address: 500 River Ridge Drive, Norwood, MA, United States, 02062
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service